Literature DB >> 32434990

Self-assembling influenza nanoparticle vaccines drive extended germinal center activity and memory B cell maturation.

Hannah G Kelly1,2, Hyon-Xhi Tan1, Jennifer A Juno1, Robyn Esterbauer1,2, Yi Ju2,3, Wenbo Jiang1, Verena C Wimmer4, Brigette C Duckworth5, Joanna R Groom5, Frank Caruso2,3, Masaru Kanekiyo6, Stephen J Kent1,2,7, Adam K Wheatley1,2.   

Abstract

Protein-based, self-assembling nanoparticles elicit superior immunity compared with soluble protein vaccines, but the immune mechanisms underpinning this effect remain poorly defined. Here, we investigated the immunogenicity of a prototypic ferritin-based nanoparticle displaying influenza hemagglutinin (HA) in mice and macaques. Vaccination of mice with HA-ferritin nanoparticles elicited higher serum antibody titers and greater protection against experimental influenza challenge compared with soluble HA protein. Germinal centers in the draining lymph nodes were expanded and persistent following HA-ferritin vaccination, with greater deposition of antigen that colocalized with follicular dendritic cells. Our findings suggest that a highly ordered and repetitive antigen array may directly drive germinal centers through a B cell-intrinsic mechanism that does not rely on ferritin-specific T follicular helper cells. In contrast to mice, enhanced immunogenicity of HA-ferritin was not observed in pigtail macaques, where antibody titers and lymph node immunity were comparable to soluble vaccination. An improved understanding of factors that drive nanoparticle vaccine immunogenicity in small and large animal models will facilitate the clinical development of nanoparticle vaccines for broad and durable protection against diverse pathogens.

Entities:  

Keywords:  Adaptive immunity; Immunology; Influenza; Nanotechnology; Vaccines

Mesh:

Substances:

Year:  2020        PMID: 32434990      PMCID: PMC7259527          DOI: 10.1172/jci.insight.136653

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  50 in total

1.  Identification of murine antigen-specific T follicular helper cells using an activation-induced marker assay.

Authors:  Wenbo Jiang; Kathleen M Wragg; Hyon-Xhi Tan; Hannah G Kelly; Adam K Wheatley; Stephen J Kent; Jennifer A Juno
Journal:  J Immunol Methods       Date:  2019-02-22       Impact factor: 2.303

2.  Antibody Responses with Fc-Mediated Functions after Vaccination of HIV-Infected Subjects with Trivalent Influenza Vaccine.

Authors:  Anne B Kristensen; William N Lay; Fernanda Ana-Sosa-Batiz; Hillary A Vanderven; Vijaya Madhavi; Karen L Laurie; Louise Carolan; Bruce D Wines; Mark Hogarth; Adam K Wheatley; Stephen J Kent
Journal:  J Virol       Date:  2016-05-27       Impact factor: 5.103

3.  Flow cytometry reveals that H5N1 vaccination elicits cross-reactive stem-directed antibodies from multiple Ig heavy-chain lineages.

Authors:  James R R Whittle; Adam K Wheatley; Lan Wu; Daniel Lingwood; Masaru Kanekiyo; Steven S Ma; Sandeep R Narpala; Hadi M Yassine; Gregory M Frank; Jonathan W Yewdell; Julie E Ledgerwood; Chih-Jen Wei; Adrian B McDermott; Barney S Graham; Richard A Koup; Gary J Nabel
Journal:  J Virol       Date:  2014-02-05       Impact factor: 5.103

4.  Slow Delivery Immunization Enhances HIV Neutralizing Antibody and Germinal Center Responses via Modulation of Immunodominance.

Authors:  Kimberly M Cirelli; Diane G Carnathan; Bartek Nogal; Jacob T Martin; Oscar L Rodriguez; Amit A Upadhyay; Chiamaka A Enemuo; Etse H Gebru; Yury Choe; Federico Viviano; Catherine Nakao; Matthias G Pauthner; Samantha Reiss; Christopher A Cottrell; Melissa L Smith; Raiza Bastidas; William Gibson; Amber N Wolabaugh; Mariane B Melo; Benjamin Cossette; Venkatesh Kumar; Nirav B Patel; Talar Tokatlian; Sergey Menis; Daniel W Kulp; Dennis R Burton; Ben Murrell; William R Schief; Steven E Bosinger; Andrew B Ward; Corey T Watson; Guido Silvestri; Darrell J Irvine; Shane Crotty
Journal:  Cell       Date:  2019-05-09       Impact factor: 41.582

5.  Complement proteins bind to nanoparticle protein corona and undergo dynamic exchange in vivo.

Authors:  Fangfang Chen; Guankui Wang; James I Griffin; Barbara Brenneman; Nirmal K Banda; V Michael Holers; Donald S Backos; LinPing Wu; Seyed Moein Moghimi; Dmitri Simberg
Journal:  Nat Nanotechnol       Date:  2016-12-19       Impact factor: 39.213

6.  Evolution of the mannose-binding lectin gene in primates.

Authors:  M V Verga Falzacappa; L Segat; B Puppini; A Amoroso; S Crovella
Journal:  Genes Immun       Date:  2004-12       Impact factor: 2.676

7.  Phylogenetic nomenclature and evolution of mannose-binding lectin (MBL2) haplotypes.

Authors:  Angelica B W Boldt; Iara J Messias-Reason; Diogo Meyer; Carlos G Schrago; Florian Lang; Bertrand Lell; Klaus Dietz; Peter G Kremsner; Maria Luiza Petzl-Erler; Jürgen F J Kun
Journal:  BMC Genet       Date:  2010-05-14       Impact factor: 2.797

8.  Reconstituted B cell receptor signaling reveals carbohydrate-dependent mode of activation.

Authors:  Rina F Villar; Jinal Patel; Grant C Weaver; Masaru Kanekiyo; Adam K Wheatley; Hadi M Yassine; Catherine E Costello; Kevin B Chandler; Patrick M McTamney; Gary J Nabel; Adrian B McDermott; John R Mascola; Steven A Carr; Daniel Lingwood
Journal:  Sci Rep       Date:  2016-10-31       Impact factor: 4.379

9.  Design of Nanoparticulate Group 2 Influenza Virus Hemagglutinin Stem Antigens That Activate Unmutated Ancestor B Cell Receptors of Broadly Neutralizing Antibody Lineages.

Authors:  Kizzmekia S Corbett; Syed M Moin; Hadi M Yassine; Alberto Cagigi; Masaru Kanekiyo; Seyhan Boyoglu-Barnum; Sky I Myers; Yaroslav Tsybovsky; Adam K Wheatley; Chaim A Schramm; Rebecca A Gillespie; Wei Shi; Lingshu Wang; Yi Zhang; Sarah F Andrews; M Gordon Joyce; Michelle C Crank; Daniel C Douek; Adrian B McDermott; John R Mascola; Barney S Graham; Jeffrey C Boyington
Journal:  MBio       Date:  2019-02-26       Impact factor: 7.867

10.  A population-based study of morbidity and mortality in mannose-binding lectin deficiency.

Authors:  Morten Dahl; Anne Tybjaerg-Hansen; Peter Schnohr; Børge G Nordestgaard
Journal:  J Exp Med       Date:  2004-05-17       Impact factor: 14.307

View more
  16 in total

1.  Engineered Nanoparticulate Vaccines to Combat Recurring and Pandemic Influenza Threats.

Authors:  Chunhong Dong; Bao-Zhong Wang
Journal:  Adv Nanobiomed Res       Date:  2021-12-07

2.  Chimeric Antigen by the Fusion of SARS-CoV-2 Receptor Binding Domain with the Extracellular Domain of Human CD154: A Promising Improved Vaccine Candidate.

Authors:  Ileanet Ávalos; Thailin Lao; Elsa María Rodríguez; Yasser Zamora; Alianet Rodríguez; Ailyn Ramón; Gilda Lemos; Ania Cabrales; Monica Bequet-Romero; Dionne Casillas; Ivan Andújar; Luis Ariel Espinosa; Luis Javier González; Yanitza Alvarez; Yamila Carpio; Mario Pablo Estrada
Journal:  Vaccines (Basel)       Date:  2022-06-03

3.  Nanoparticle Vaccines Based on the Receptor Binding Domain (RBD) and Heptad Repeat (HR) of SARS-CoV-2 Elicit Robust Protective Immune Responses.

Authors:  Xiancai Ma; Fan Zou; Fei Yu; Rong Li; Yaochang Yuan; Yiwen Zhang; Xiantao Zhang; Jieyi Deng; Tao Chen; Zheng Song; Yidan Qiao; Yikang Zhan; Jun Liu; Junsong Zhang; Xu Zhang; Zhilin Peng; Yuzhuang Li; Yingtong Lin; Liting Liang; Guanwen Wang; Yingshi Chen; Qier Chen; Ting Pan; Xin He; Hui Zhang
Journal:  Immunity       Date:  2020-11-25       Impact factor: 31.745

4.  Aggregation by peptide conjugation rescues poor immunogenicity of the HA stem.

Authors:  Wenbo Jiang; Emily H Pilkington; Hannah G Kelly; Hyon-Xhi Tan; Jennifer A Juno; Adam K Wheatley; Stephen J Kent
Journal:  PLoS One       Date:  2020-11-02       Impact factor: 3.240

5.  Development of spike receptor-binding domain nanoparticle as a vaccine candidate against SARS-CoV-2 infection in ferrets.

Authors:  Young-Il Kim; Dokyun Kim; Kwang-Min Yu; Hogyu David Seo; Shin-Ae Lee; Mark Anthony B Casel; Seung-Gyu Jang; Stephanie Kim; WooRam Jung; Chih-Jen Lai; Young Ki Choi; Jae U Jung
Journal:  bioRxiv       Date:  2021-01-29

6.  Screening and development of monoclonal antibodies for identification of ferret T follicular helper cells.

Authors:  Wenbo Jiang; Julius Wong; Hyon-Xhi Tan; Hannah G Kelly; Paul G Whitney; Ian Barr; Daniel S Layton; Stephen J Kent; Adam K Wheatley; Jennifer A Juno
Journal:  Sci Rep       Date:  2021-01-21       Impact factor: 4.379

7.  Immunofocusing and enhancing autologous Tier-2 HIV-1 neutralization by displaying Env trimers on two-component protein nanoparticles.

Authors:  Philip J M Brouwer; Aleksandar Antanasijevic; Marlon de Gast; Joel D Allen; Tom P L Bijl; Anila Yasmeen; Rashmi Ravichandran; Judith A Burger; Gabriel Ozorowski; Jonathan L Torres; Celia LaBranche; David C Montefiori; Rajesh P Ringe; Marit J van Gils; John P Moore; Per Johan Klasse; Max Crispin; Neil P King; Andrew B Ward; Rogier W Sanders
Journal:  NPJ Vaccines       Date:  2021-02-09       Impact factor: 7.344

Review 8.  Conversations that count: Cellular interactions that drive T cell fate.

Authors:  Brigette C Duckworth; Joanna R Groom
Journal:  Immunol Rev       Date:  2021-02-14       Impact factor: 12.988

9.  Development of Spike Receptor-Binding Domain Nanoparticles as a Vaccine Candidate against SARS-CoV-2 Infection in Ferrets.

Authors:  Young-Il Kim; Dokyun Kim; Kwang-Min Yu; Hogyu David Seo; Shin-Ae Lee; Mark Anthony B Casel; Seung-Gyu Jang; Stephanie Kim; WooRam Jung; Chih-Jen Lai; Young Ki Choi; Jae U Jung
Journal:  mBio       Date:  2021-03-02       Impact factor: 7.867

Review 10.  Antibody Focusing to Conserved Sites of Vulnerability: The Immunological Pathways for 'Universal' Influenza Vaccines.

Authors:  Maya Sangesland; Daniel Lingwood
Journal:  Vaccines (Basel)       Date:  2021-02-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.